Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.

Neale J, Tompkins CNE, Strang J.

Drug Alcohol Rev. 2019 May 26. doi: 10.1111/dar.12939. [Epub ahead of print]

PMID:
31131514
2.

Causes of death among homeless people: a population-based cross-sectional study of linked hospitalisation and mortality data in England.

Aldridge RW, Menezes D, Lewer D, Cornes M, Evans H, Blackburn RM, Byng R, Clark M, Denaxas S, Fuller J, Hewett N, Kilmister A, Luchenski S, Manthorpe J, McKee M, Neale J, Story A, Tinelli M, Whiteford M, Wurie F, Hayward A.

Wellcome Open Res. 2019 Mar 11;4:49. doi: 10.12688/wellcomeopenres.15151.1. eCollection 2019.

3.
4.

Factors influencing recruitment to a randomised placebo-controlled trial of oral naltrexone and extended release implant naltrexone: Qualitative study.

Tompkins CNE, Neale J, Marsden J, Strang J.

J Subst Abuse Treat. 2019 Apr;99:52-60. doi: 10.1016/j.jsat.2019.01.012. Epub 2019 Jan 16.

PMID:
30797394
5.

Take-home naloxone and the politics of care.

Farrugia A, Fraser S, Dwyer R, Fomiatti R, Neale J, Dietze P, Strang J.

Sociol Health Illn. 2019 Feb;41(2):427-443. doi: 10.1111/1467-9566.12848.

PMID:
30710415
6.

Challenges in delivering personalised support to people with multiple and complex needs: qualitative study.

Neale J, Parkman T, Strang J.

J Interprof Care. 2018 Dec 10:1-10. doi: 10.1080/13561820.2018.1553869. [Epub ahead of print]

PMID:
30526196
7.

Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?

Madden A, Hopwood M, Neale J, Treloar C.

PLoS One. 2018 Nov 30;13(11):e0207226. doi: 10.1371/journal.pone.0207226. eCollection 2018.

8.

How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.

Neale J, Brown C, Campbell ANC, Jones JD, Metz VE, Strang J, Comer SD.

Addiction. 2019 Apr;114(4):708-718. doi: 10.1111/add.14510. Epub 2018 Dec 28.

PMID:
30476356
9.

Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs.

Madden A, Hopwood M, Neale J, Treloar C.

Patient. 2019 Apr;12(2):259-265. doi: 10.1007/s40271-018-0332-6.

PMID:
30270403
10.

Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.

Madden A, Hopwood M, Neale J, Treloar C.

Harm Reduct J. 2018 Aug 15;15(1):42. doi: 10.1186/s12954-018-0248-4.

11.

Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making.

Neale J, Tompkins CNE, McDonald R, Strang J.

Exp Clin Psychopharmacol. 2018 Dec;26(6):570-581. doi: 10.1037/pha0000217. Epub 2018 Jul 23.

PMID:
30035579
12.

Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin.

Neale J, Tompkins CNE, McDonald R, Strang J.

Drug Alcohol Depend. 2018 Aug 1;189:1-7. doi: 10.1016/j.drugalcdep.2018.03.057. Epub 2018 May 25.

13.

Building on feminist achievements to enhance choice for women seeking treatment.

Neale J, Tompkins CNE, Marshall AD, Treloar C, Strang J.

Addiction. 2018 Jun;113(6):1001-1002. doi: 10.1111/add.14226. No abstract available.

PMID:
29732702
14.

It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis.

Hall W, West R, Marsden J, Humphreys K, Neale J, Petry N.

Addiction. 2018 Jun;113(6):987-988. doi: 10.1111/add.14139. Epub 2018 Feb 22. No abstract available.

PMID:
29468760
15.

Do women with complex alcohol and other drug use histories want women-only residential treatment?

Neale J, Tompkins CNE, Marshall AD, Treloar C, Strang J.

Addiction. 2018 Jun;113(6):989-997. doi: 10.1111/add.14131. Epub 2018 Jan 24.

16.

Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.

Neale J, Tompkins CNE, McDonald R, Strang J.

Addiction. 2018 Jun;113(6):1066-1076. doi: 10.1111/add.14163. Epub 2018 Feb 21.

17.

Development and early validation of a patient-reported outcome measure to assess sleep amongst people experiencing problems with alcohol or other drugs.

Neale J, Vitoratou S, Lennon P, Meadows R, Nettleton S, Panebianco D, Strang J, Marsden J.

Sleep. 2018 Apr 1;41(4). doi: 10.1093/sleep/zsy013.

18.

Substance use, sleep and intervention design: insights from qualitative data.

Neale J, Meadows R, Nettleton S, Panebianco D, Strang J, Vitoratou S, Marsden J.

J Ment Health. 2017 Dec 21:1-8. doi: 10.1080/09638237.2017.1417560. [Epub ahead of print]

PMID:
29265898
19.

Outcomes of specialist discharge coordination and intermediate care schemes for patients who are homeless: analysis protocol for a population-based historical cohort.

Blackburn RM, Hayward A, Cornes M, McKee M, Lewer D, Whiteford M, Menezes D, Luchenski S, Story A, Denaxas S, Tinelli M, Wurie FB, Byng R, Clark MC, Fuller J, Gabbay M, Hewett N, Kilmister A, Manthorpe J, Neale J, Aldridge RW.

BMJ Open. 2017 Dec 14;7(12):e019282. doi: 10.1136/bmjopen-2017-019282.

20.

Toxicity: exploring and expanding the concept.

Strang J, Neale J, McDonald R, Kalk N.

Addiction. 2018 Apr;113(4):592-594. doi: 10.1111/add.14080. Epub 2017 Dec 4. No abstract available.

PMID:
29205614

Supplemental Content

Loading ...
Support Center